A ID8 scr sh cx2 cx3 cx6 B C Supplementary Figure 4. The fractalkine axis does not regulate ascites formation.

Slides:



Advertisements
Similar presentations
© red ©
Advertisements

If you say 8 color the ones in your picture purple. If you say 9 color the ones in your picture blue.
Color Distribution A block BrownYellowOrangeRedGreenBlue GreenYellowOrangeRedPurple M&M Skittles.
Date of download: 6/3/2016 Copyright © 2016 SPIE. All rights reserved. (a) Confocal microscope images of human adipose-derived stem cells (hASCs) labeled.
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 12, Issue 5, Pages (November 2007)
Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice Urzua Ulises 1, 4, 5 ;Chacon Carlos 1 ;Lizama.
Development of a Rab9 Transgenic Mouse and Its Ability to Increase the Lifespan of a Murine Model of Niemann-Pick Type C Disease  Tatiana Kaptzan, Sally.
Attema et al., Supplementary Figure 1
Volume 18, Issue 8, Pages (February 2017)
Volume 12, Issue 5, Pages (November 2007)
Volume 19, Issue 3, Pages (March 2011)
Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.
Volume 72, Issue 4, Pages (October 2017)
Volume 137, Issue 2, Pages e2 (August 2009)
Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models  Andrey.
Volume 85, Issue 4, Pages (April 2014)
Volume 66, Issue 4, Pages (October 2014)
Volume 42, Issue 3, Pages (March 2015)
Volume 2, Issue 4, Pages (April 2008)
P53 Mediates Vast Gene Expression Changes That Contribute to Poor Chemotherapeutic Response in a Mouse Model of Breast Cancer  Crystal Tonnessen-Murray,
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 6, Issue 5, Pages (March 2014)
In vivo responses of AMLMLL to ATRi.
Can I color yellow?. Can I color yellow?
Expression of FUT9 supports tumor development
Fig. 8. In vivo suppression of MM by CMLD
Notch Activation as a Driver of Osteogenic Sarcoma
CXCL5 as Regulator of Neutrophil Function in Cutaneous Melanoma
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death  Hilary Clay, Hannah E. Volkman,
Molecular Classification of Renal Tumors by Gene Expression Profiling
Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant  A. Gomis, S. Meini, A. Miralles,
Transcriptional Landscape of Cardiomyocyte Maturation
Volume 15, Issue 5, Pages (May 2007)
Identification of Modifier Genes in a Mouse Model of Gaucher Disease
Volume 36, Issue 3, Pages (March 2012)
Volume 123, Issue 6, Pages (December 2005)
Fig. 5 Combination intravenous reovirus and checkpoint inhibition in an orthotopic syngeneic brain tumor model. Combination intravenous reovirus and checkpoint.
What Color is it?.
Molecular Therapy - Oncolytics
Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.
Volume 16, Issue 11, Pages (September 2016)
Fig. 7 BRD0705 impairs colony formation in AML cell lines and patient cells and shows in vivo efficacy in multiple AML mouse models. BRD0705 impairs colony.
Volume 22, Issue 12, Pages (March 2018)
Fig. 4. Improved tumor response to docetaxel in TNBC and trastuzumab in HER2-amplified PDX models with the addition of S Improved tumor response.
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma  Alessandra Lopes, Kevin Vanvarenberg, Véronique Préat,
Volume 9, Issue 4, Pages (November 2014)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia by Elizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski,
Volume 15, Issue 3, Pages (March 2009)
Fig. 7. mRIPO therapy restricts tumor growth and produces antigen-specific antitumor immunity. mRIPO therapy restricts tumor growth and produces antigen-specific.
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death  Hilary Clay, Hannah E. Volkman,
Volume 18, Issue 8, Pages (February 2017)
Lukxmi Balathasan, Vera A
Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.
Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri  Hideaki Matsui, Naoya.
Genetic EGFR ablation in K-RAS–mutated lung AC reduces tumor growth
Nutrient availability regulates growth of the X. laevis optic tectum.
MRP2 inhibition mitigates pulmonary burden and bacteremia following lung challenge with S. pneumoniae. MRP2 inhibition mitigates pulmonary burden and bacteremia.
Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.
A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis
XBP-1 Remodels Lipid Metabolism to Extend Longevity
Supplementary figure 1 A B Water (Control) Pre-alcohol Post-alcohol
Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.
X-tile analysis of survival data from the SEER registry reveals a continuous distribution based on tumor size and node number, and a U-shaped distribution.
Supplementary Figure S1
Expression of XCR1 in normal ovarian surface epithelium and the IOSE and borderline EOC cell lines. Expression of XCR1 in normal ovarian surface epithelium.
A to C, MetMAb shows strong antitumor activity in the KP4 orthotopic model of pancreatic cancer by ultrasound. A to C, MetMAb shows strong antitumor activity.
Fig. 5 In vivo autologous self-targeting efficacy of DR-KO tumor cells co-engineered with a secretable DRL and a suicide system. In vivo autologous self-targeting.
A. B. C. D. Above median: Below median:
Presentation transcript:

A ID8 scr sh cx2 cx3 cx6 B C Supplementary Figure 4. The fractalkine axis does not regulate ascites formation. Survival (A) and ascites formation (B) in animals bearing tumors formed by i.p. injecting ID8, scr sh, cx2, cx3, and cx6 cells as well as PBS into abdomens of C57BL/6 mice. Mice injected with phosphate buffered saline (PBS) served as a control; animals in this group did not develop any pathologic conditions over the course of the experiments and were sacrificed at the time when the last experimental animal reached humane endpoints, i.e. 515 days after i.p. injection of PBS, reaching a total lifespan of 1.5 years. Kaplan-Meier plot was used to estimate survival. Median survival was found using Prizm software and plotted on the graph. Difference in survival between the experimental (cx2, cx3, cx6) and control groups (ID8, scr sh) was statistically analysed using Log-rank (Mantel-Cox) test and Gehan-Breslow-Wilcoxon test; p>0.05. Color coding for the control and experimental animal groups : blue – PBS, red – ID8, green – scr sh, purple – cx2, orange – cx3, black– cx6. Typical image of animals presenting with ascites is shown (B, right panel). (C) Expression of CX3CL1 in specimens of lymph node was detected using immunohistochemistry. Image of CX3CL1 immunostaining in normal lymph node of epiploon corresponds to the case D7 (Supplementary Table 2). Brown, CX3CL1; blue, hematoxylin. Images were generated using Aperio ScanScope. The right panel is a magnified image outlined in the left panel. Bar, 500 (left panel) and 100 (right panel) micron.